Medical college | Page 6 of 23

Lung :: Antibodies protect mice from developing respiratory tularemia

A research team led by Dennis W. Metzger, Ph.D., at the Albany Medical College in New York has now shown that treating laboratory mice with a serum containing tularemia-specific antibodies protects the mice against F. tularensis, not only if given before exposure to lethal doses of inhalational F. tularensis but also up to 48 hours after exposure. These findings suggest a possible alternative treatment approach to traditional antibiotics.

Parkinson’s Disease :: Gene therapy promising for Parkinson’s disease patients

The first-ever phase 1 clinical trial using gene therapy to battle Parkinson’s disease is completed by a team led by physician-scientists at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.

Obesity :: Clock Gene Plays Role in Weight Gain

Scientists at the University of Virginia and the Medical College of Wisconsin have discovered that a gene that participates in the regulation of the body?s biological rhythms may also be a major control in regulating metabolism.

Cancer :: Weill Cornell team identifies potential new cancer drug target

Research led by scientists at Weill Cornell Medical College has uncovered two new potential points of vulnerability on a key cancer-promoting protein, called XIAP. Drugs that target either of these activities could help push cancer cells back into a more regular programmed cell death and thereby reduce or eliminate tumors.

Pancreatic Cancer :: Marker predicts pancreatic cancer outcome after surgery, Jefferson surgeon finds

A team of researchers, led by surgeons at the Kimmel Cancer Center at Jefferson in Philadelphia, has found further evidence supporting the ability of a protein to predict how well a patient with advanced pancreatic cancer will do after surgery, chemotherapy and radiation.

Parkinson’s Disease :: Promising results from gene therapy clinical trial for Parkinson’s disease

In what could be a breakthrough in the treatment of neurological disease, a team led by physician-scientists at NewYork-Presbyterian Hospital/Weill Cornell Medical Center has completed the first-ever phase 1 clinical trial using gene therapy to battle Parkinson’s disease.

Alzheimer’s Disease :: Paving the way toward a vaccine against Alzheimer’s disease

Scientists have provided new details about how proteins used to destroy bacteria and viruses may help treat Alzheimer?s disease. Gunnar K. Gouras, associate professor of neurology and neuroscience at Weill Medical College of Cornell University, New York, and colleagues provide new insights into how these proteins, called antibodies, reduce the main hallmarks of Alzheimer?s disease and raise hopes for a vaccine against the disease.

HIV :: Mucosal-surface immune function discoveries could boost vaccine research

In a finding that could have important implications for HIV vaccine research, new research at Weill Cornell Medical College illuminates the ways in which the body prevents its mucosal surfaces from being overwhelmed by bacteria.

Imaging :: Methodist, University of Houston, Cornell combine biomedical imaging expertise

The Methodist Hospital, the University of Houston, and Weill Cornell Medical College of Cornell University are combining their expertise in biomedical imaging to advance discoveries in this growing field of biomedical science and its clinical applications.

Brain :: Bird song study gives clues to human stuttering

Researchers at the Methodist Neurological Institute in Houston and Weill Cornell Medical College in New York City used functional MRI to determine that songbirds have a pronounced right-brain response to the sound of songs, establishing a foundational study for future research on songbird models of speech disorders such as stuttering, as reported today in Proceedings of the National Academy of Sciences.